International long‐term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0–19 years

To enhance understanding of etiology, we examined international population‐based cancer incidence data for lymphoid leukemia, non‐Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0–19. Based on temporal trends during 1978–2007 in 24 populations, lymphoid leukemia and myelo...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 138; no. 8; pp. 1862 - 1874
Main Authors Linet, Martha S., Brown, Linda M., Mbulaiteye, Sam M., Check, David, Ostroumova, Evgenia, Landgren, Annelie, Devesa, Susan S.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 15.04.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To enhance understanding of etiology, we examined international population‐based cancer incidence data for lymphoid leukemia, non‐Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0–19. Based on temporal trends during 1978–2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non‐Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003–2007 in 54 populations varied about 10‐fold, with rates highest in US white Hispanics (50.2 per million person‐years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non‐Hodgkin lymphoma rates varied 30‐fold, with very high rates in sub‐Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian‐Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15‐fold, with rates highest in Italy (21.3) and lowest in China (1.7) . Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age‐specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world‐wide, except for non‐Hodgkin lymphoma. A systematic world‐wide approach comparing postulated etiologic factors in low‐ versus high‐risk populations may help clarify the etiology of these childhood malignancies. What's new? This first study to assess systematically long‐term (1978–2007) incidence trends for childhood leukemias and lymphomas across five continents found that lymphoid and myeloid leukemia rates generally have not changed greatly, while regional differences in non‐Hodgkin and Hodgkin lymphoma rates have diminished over time. During 2003–2007 age‐adjusted incidence rates spanning five continents for non‐Hodgkin lymphoma have varied 30‐fold, Hodgkin lymphoma 15‐fold, lymphoid leukemia 10‐fold, and myeloid leukemia only 5‐fold.
AbstractList To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤ 10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7). Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies.To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤ 10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7). Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies.
To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates ( less than or equal to 10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7) . Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies. What's new? This first study to assess systematically long-term (1978-2007) incidence trends for childhood leukemias and lymphomas across five continents found that lymphoid and myeloid leukemia rates generally have not changed greatly, while regional differences in non-Hodgkin and Hodgkin lymphoma rates have diminished over time. During 2003-2007 age-adjusted incidence rates spanning five continents for non-Hodgkin lymphoma have varied 30-fold, Hodgkin lymphoma 15-fold, lymphoid leukemia 10-fold, and myeloid leukemia only 5-fold.
To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (?10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7) . Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies. What's new? This first study to assess systematically long-term (1978-2007) incidence trends for childhood leukemias and lymphomas across five continents found that lymphoid and myeloid leukemia rates generally have not changed greatly, while regional differences in non-Hodgkin and Hodgkin lymphoma rates have diminished over time. During 2003-2007 age-adjusted incidence rates spanning five continents for non-Hodgkin lymphoma have varied 30-fold, Hodgkin lymphoma 15-fold, lymphoid leukemia 10-fold, and myeloid leukemia only 5-fold.
To enhance understanding of etiology, we examined international population‐based cancer incidence data for lymphoid leukemia, non‐Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0–19. Based on temporal trends during 1978–2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non‐Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003–2007 in 54 populations varied about 10‐fold, with rates highest in US white Hispanics (50.2 per million person‐years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non‐Hodgkin lymphoma rates varied 30‐fold, with very high rates in sub‐Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian‐Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15‐fold, with rates highest in Italy (21.3) and lowest in China (1.7) . Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age‐specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world‐wide, except for non‐Hodgkin lymphoma. A systematic world‐wide approach comparing postulated etiologic factors in low‐ versus high‐risk populations may help clarify the etiology of these childhood malignancies. What's new? This first study to assess systematically long‐term (1978–2007) incidence trends for childhood leukemias and lymphomas across five continents found that lymphoid and myeloid leukemia rates generally have not changed greatly, while regional differences in non‐Hodgkin and Hodgkin lymphoma rates have diminished over time. During 2003–2007 age‐adjusted incidence rates spanning five continents for non‐Hodgkin lymphoma have varied 30‐fold, Hodgkin lymphoma 15‐fold, lymphoid leukemia 10‐fold, and myeloid leukemia only 5‐fold.
To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and myeloid leukemia among children aged 0-19. Based on temporal trends during 1978-2007 in 24 populations, lymphoid leukemia and myeloid leukemia incidence rates generally have not changed greatly and differences in rates for non-Hodgkin and for Hodgkin lymphoma have diminished in some regions. Lymphoid leukemia rates during 2003-2007 in 54 populations varied about 10-fold, with rates highest in US white Hispanics (50.2 per million person-years) and Ecuador (48.3) and lowest in US blacks (20.4), Tunisia (17.7) and Uganda (6.9). Non-Hodgkin lymphoma rates varied 30-fold, with very high rates in sub-Saharan Africa (146.0 in Malawi and 54.3 in Uganda) and low rates (≤ 10) in some Asian populations (China, Japan, India, the Philippines and Thailand) and U.S. Asian-Pacific Islanders, eastern and northern European populations and Puerto Rico. Hodgkin lymphoma rates varied 15-fold, with rates highest in Italy (21.3) and lowest in China (1.7). Myeloid leukemia rates varied only about fivefold, with rates highest in the Philippines and Korea (exceeding 14.0) and lowest in Eastern Europe (5.9 in Serbia and 5.3 in the Czech Republic) and Uganda (2.7). The boy/girl average incidence rate ratios were 2.00 or lower. Age-specific patterns differed among the four hematopoietic malignancies, but were generally consistent within major categories world-wide, except for non-Hodgkin lymphoma. A systematic world-wide approach comparing postulated etiologic factors in low- versus high-risk populations may help clarify the etiology of these childhood malignancies.
Author Linet, Martha S.
Check, David
Mbulaiteye, Sam M.
Brown, Linda M.
Ostroumova, Evgenia
Landgren, Annelie
Devesa, Susan S.
Author_xml – sequence: 1
  givenname: Martha S.
  surname: Linet
  fullname: Linet, Martha S.
  organization: National Cancer Institute, NIH
– sequence: 2
  givenname: Linda M.
  surname: Brown
  fullname: Brown, Linda M.
  organization: RTI International
– sequence: 3
  givenname: Sam M.
  surname: Mbulaiteye
  fullname: Mbulaiteye, Sam M.
  organization: National Cancer Institute, NIH
– sequence: 4
  givenname: David
  surname: Check
  fullname: Check, David
  organization: National Cancer Institute, NIH
– sequence: 5
  givenname: Evgenia
  surname: Ostroumova
  fullname: Ostroumova, Evgenia
  organization: National Cancer Institute, NIH
– sequence: 6
  givenname: Annelie
  surname: Landgren
  fullname: Landgren, Annelie
  organization: National Cancer Institute, NIH
– sequence: 7
  givenname: Susan S.
  surname: Devesa
  fullname: Devesa, Susan S.
  organization: National Cancer Institute, NIH
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26562742$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1uEzEUhS1URNPCghdAltjAYlr_zY-XKOInqBIbWI9sz03j4LGD7VGVXR8BxBv2SfAkhUUlEKsr3_OdoyufM3TigweEnlNyQQlhl3ZrLpiUTDxCC0pkWxFG6xO0KBqpWsqbU3SW0pYQSmsinqBT1tQNawVboB8rnyF6lW3wymEX_PXd7feyGnGO4IeElR9wBAM-453KM5yw9ThvoAxjB_AGcFhjB9NXGK06Otx-3G3COL_GkonNxrqhBB5ENQQHaY4s8jUkTO5uf1KJ96Bieooer5VL8Ox-nqMv795-Xn6orj69Xy3fXFVGMCqqhjUMTKOlMCC51kNDoAZVKym4HExX1oq0RNdMk7buONNdB4KvjTZaCNryc_TqmLuL4dsEKfejLTc5pzyEKfW07WrGKaX8P9BGUN7JThT05QN0G6byv-5AMcnrls2BL-6pSY8w9LtoRxX3_e9eCvD6CJgYUoqw_oNQ0s-d96Xz_tB5YS8fsMbmQ6E5Kuv-5bixDvZ_j-5XH5dHxy9BVr8_
CitedBy_id crossref_primary_10_2217_fon_2017_0276
crossref_primary_10_1002_ijc_30575
crossref_primary_10_1136_bmjpo_2022_001802
crossref_primary_10_1007_s12672_022_00465_6
crossref_primary_10_1080_0284186X_2020_1738546
crossref_primary_10_1007_s10552_020_01267_3
crossref_primary_10_17533_udea_iatreia_50
crossref_primary_10_1016_j_ijheh_2018_08_004
crossref_primary_10_1186_s13000_018_0693_0
crossref_primary_10_1016_j_sste_2024_100698
crossref_primary_10_1002_cncr_30630
crossref_primary_10_1038_s41416_024_02629_3
crossref_primary_10_1371_journal_pone_0172986
crossref_primary_10_1016_j_arcmed_2016_11_017
crossref_primary_10_1007_s12094_018_1860_1
crossref_primary_10_1093_jnci_djx030
crossref_primary_10_1016_j_canep_2018_07_004
crossref_primary_10_1002_ijc_33619
crossref_primary_10_1177_2333794X17715831
crossref_primary_10_1002_ijc_32203
crossref_primary_10_1038_s41568_023_00584_4
crossref_primary_10_1016_j_ejca_2021_12_010
crossref_primary_10_1016_S1470_2045_18_30498_4
crossref_primary_10_1016_j_envres_2019_108827
crossref_primary_10_1038_s41375_020_01024_0
crossref_primary_10_3390_genes11030302
crossref_primary_10_3390_cancers13071692
crossref_primary_10_7717_peerj_18296
crossref_primary_10_1016_j_epsc_2018_01_008
crossref_primary_10_1016_j_sste_2023_100582
crossref_primary_10_1007_s00431_017_2982_0
crossref_primary_10_3390_hemato3030030
crossref_primary_10_1016_j_jncc_2022_02_001
crossref_primary_10_1186_s40359_024_01798_3
crossref_primary_10_1016_S2352_3026_17_30053_4
crossref_primary_10_1097_MPH_0000000000001105
crossref_primary_10_1080_10934529_2020_1861903
crossref_primary_10_1093_aje_kww018
crossref_primary_10_1177_09732179241304925
crossref_primary_10_1038_s41577_021_00505_2
crossref_primary_10_1080_08880018_2019_1649333
crossref_primary_10_3389_fpubh_2021_805757
crossref_primary_10_3390_ijms20030735
crossref_primary_10_1182_blood_2019004381
crossref_primary_10_1371_journal_pone_0181805
crossref_primary_10_3390_cancers15041011
crossref_primary_10_1016_j_canep_2020_101764
crossref_primary_10_1016_j_canep_2021_101965
crossref_primary_10_1016_j_leukres_2021_106585
crossref_primary_10_1186_s12885_019_6510_7
crossref_primary_10_1007_s10552_016_0817_3
crossref_primary_10_3390_ijerph14121468
crossref_primary_10_1002_hon_2776
crossref_primary_10_1016_j_phoj_2020_06_008
crossref_primary_10_1371_journal_pone_0210224
crossref_primary_10_1089_jayao_2017_0095
crossref_primary_10_1093_aje_kwz058
crossref_primary_10_1002_hon_3070
crossref_primary_10_1080_10245332_2017_1396056
crossref_primary_10_1177_1010428317697573
crossref_primary_10_18632_aging_203116
crossref_primary_10_1002_bies_202400033
crossref_primary_10_1002_cncr_30129
crossref_primary_10_1016_j_canep_2020_101851
crossref_primary_10_1186_s12885_016_2689_z
crossref_primary_10_3390_cancers15143653
Cites_doi 10.1002/pbc.22383
10.1016/j.ejca.2006.06.001
10.1093/jnci/66.6.1192
10.1038/sj.leu.2402252
10.1016/j.eururo.2012.02.054
10.1146/annurev-publhealth-031912-114350
10.1002/ijc.2910080203
10.1016/S0140-6736(01)05581-7
10.1016/j.cbi.2012.01.007
10.1016/S0140-6736(04)17550-8
10.1038/bjc.1996.219
10.1111/j.1365-3016.1990.tb00654.x
10.1002/ijc.2910320609
10.1002/ajh.23187
10.3322/caac.21219
10.1093/jnci/djg064
10.1093/aje/141.4.300
10.1002/ijc.28222
10.1002/ijc.23226
10.3109/02841869209108173
10.1016/j.ctrv.2010.02.004
10.1093/jnci/85.22.1819
10.1002/cncr.23169
10.1016/j.ejca.2006.05.005
10.1002/cncr.28749
10.1016/j.ejca.2006.06.005
10.1177/030089167606200203
10.1038/bjc.1982.90
10.1002/ijc.2910610204
10.1158/1055-9965.EPI-15-0535
10.1016/j.taap.2003.12.032
10.1093/acprof:oso/9780195149616.003.0065
10.1016/j.ejca.2006.05.012
10.1046/j.1365-3016.2002.00422.x
10.1002/ijc.2910610108
10.1038/bjc.1991.98
10.1093/jnci/91.12.1051
10.1002/ijc.2910550111
ContentType Journal Article
Copyright 2015 UICC
2015 UICC.
2016 UICC
Copyright_xml – notice: 2015 UICC
– notice: 2015 UICC.
– notice: 2016 UICC
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
DOI 10.1002/ijc.29924
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 1874
ExternalDocumentID 3945374081
26562742
10_1002_ijc_29924
IJC29924
Genre article
Research Support, U.S. Gov't, P.H.S
Journal Article
Research Support, N.I.H., Intramural
GrantInformation_xml – fundername: Intramural Research Program of the National Institutes of Health, National Cancer Institute, and the U.S. Public Health Service of the Department of Health and Human Services.
– fundername: Intramural NIH HHS
GroupedDBID ---
-~X
.3N
.GA
05W
0R~
10A
1L6
1OB
1OC
1ZS
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIAGR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RX1
RYL
SUPJJ
TEORI
UB1
UDS
V2E
V8K
V9Y
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAHHS
AAYXX
ACCFJ
ADZOD
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
ID FETCH-LOGICAL-c4214-6262ec6b94ce93bbd60e5ea5a9439dc84cea070b52b075832b88e43fcbcb44173
IEDL.DBID DR2
ISSN 0020-7136
1097-0215
IngestDate Thu Jul 10 17:53:49 EDT 2025
Thu Jul 10 23:44:35 EDT 2025
Sun Jul 13 04:17:51 EDT 2025
Thu Apr 03 07:06:54 EDT 2025
Thu Apr 24 23:06:56 EDT 2025
Tue Jul 01 02:28:16 EDT 2025
Wed Aug 20 07:24:42 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords myeloid leukemia
childhood
lymphoid leukemia
non-Hodgkin lymphoma
incidence
trends
Hodgkin lymphoma
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2015 UICC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4214-6262ec6b94ce93bbd60e5ea5a9439dc84cea070b52b075832b88e43fcbcb44173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.29924
PMID 26562742
PQID 1762935723
PQPubID 105430
PageCount 13
ParticipantIDs proquest_miscellaneous_1785231113
proquest_miscellaneous_1764138984
proquest_journals_1762935723
pubmed_primary_26562742
crossref_primary_10_1002_ijc_29924
crossref_citationtrail_10_1002_ijc_29924
wiley_primary_10_1002_ijc_29924_IJC29924
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 15 April 2016
PublicationDateYYYYMMDD 2016-04-15
PublicationDate_xml – month: 04
  year: 2016
  text: 15 April 2016
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle International journal of cancer
PublicationTitleAlternate Int J Cancer
PublicationYear 2016
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2012; 61
2002; 16
2004; 364
2010; 54
1976; 62
2010; 36
2005; 90
1993; 85
1998
1983; 32
2006
1996; 73
1992
2012; 59
1992; 31
2008; 122
2003; 95
1981; 66
2014; 64
2015; 24
1982; 45
2004; 199
2012; 196
1971; 8
1995; 61
2006; 42
2001
2013; 34
1991; 63
1993; 55
1988; 87
2013; 133
2001; 15
2014
2013
2008; 112
1999; 91
2014; 120
1995; 141
2012; 87
1990; 4
2001; 358
e_1_2_6_51_1
e_1_2_6_32_1
e_1_2_6_30_1
Howlader N (e_1_2_6_18_1) 2014
e_1_2_6_19_1
e_1_2_6_36_1
e_1_2_6_34_1
e_1_2_6_17_1
WHO (e_1_2_6_24_1) 1992
e_1_2_6_15_1
e_1_2_6_38_1
Brunning RD (e_1_2_6_48_1) 2001
e_1_2_6_43_1
Parkin DM (e_1_2_6_13_1) 1988; 87
e_1_2_6_20_1
e_1_2_6_41_1
e_1_2_6_9_1
e_1_2_6_5_1
e_1_2_6_7_1
Dalmasso P (e_1_2_6_37_1) 2005; 90
e_1_2_6_49_1
e_1_2_6_3_1
e_1_2_6_22_1
e_1_2_6_28_1
e_1_2_6_45_1
e_1_2_6_26_1
e_1_2_6_47_1
e_1_2_6_52_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_50_1
e_1_2_6_14_1
e_1_2_6_35_1
Munoz N. (e_1_2_6_11_1) 1976; 62
e_1_2_6_12_1
e_1_2_6_33_1
Hjalgrim H. (e_1_2_6_53_1) 2012; 59
e_1_2_6_39_1
e_1_2_6_16_1
e_1_2_6_42_1
e_1_2_6_21_1
e_1_2_6_40_1
e_1_2_6_8_1
e_1_2_6_4_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_29_1
e_1_2_6_44_1
e_1_2_6_27_1
e_1_2_6_46_1
References_xml – volume: 112
  start-page: 416
  year: 2008
  end-page: 32
  article-title: Trends in childhood cancer incidence in the U.S. (1992‐2004)
  publication-title: Cancer
– volume: 122
  start-page: 1130
  year: 2008
  end-page: 4
  article-title: Trends in childhood acute lymphoblastic leukemia in Western Australia, 1960‐2006
  publication-title: Int J Cancer
– volume: 85
  start-page: 1819
  year: 1993
  end-page: 27
  article-title: Migration patterns and breast cancer risk in Asian‐American women
  publication-title: J Natl Cancer Inst
– volume: 42
  start-page: 2150
  year: 2006
  end-page: 69
  article-title: Thyroid cancer incidence and survival among European children and adolescents (1978‐1997): Report from the Automated Childhood Cancer Information System project
  publication-title: Eur J Cancer
– volume: 31
  start-page: 275
  year: 1992
  end-page: 82
  article-title: Lymphoma incidence in a Swedish county during 1969‐1987
  publication-title: Acta Oncol
– volume: 196
  start-page: 59
  year: 2012
  end-page: 67
  article-title: Perspectives on the causes of childhood leukemia
  publication-title: Chem Biol Interact
– volume: 95
  start-page: 1539
  year: 2003
  end-page: 44
  article-title: Age‐ and sex‐specific incidence of childhood leukemia by immunophenotype in the Nordic countries
  publication-title: J Natl Cancer Inst
– volume: 73
  start-page: 1141
  year: 1996
  end-page: 7
  article-title: Childhood leukaemias in New Zealand: time trends and ethnic differences
  publication-title: Br J Cancer
– volume: 45
  start-page: 543
  year: 1982
  end-page: 51
  article-title: Trends in childhood leukaemia in Britain 1968‐1978
  publication-title: Br J Cancer
– volume: 91
  start-page: 1051
  year: 1999
  end-page: 8
  article-title: Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States
  publication-title: J Natl Cancer Inst
– start-page: 1251
  year: 2006
  end-page: 68
– year: 2001
– volume: 87
  start-page: 573
  year: 2012
  end-page: 8
  article-title: Pediatric, elderly, and emerging adult‐onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa
  publication-title: Am J Hematol
– volume: 364
  start-page: 2097
  year: 2004
  end-page: 105
  article-title: Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study
  publication-title: Lancet
– volume: 87
  start-page: 1
  year: 1988
  end-page: 401
  article-title: International incidence of childhood cancer
  publication-title: IARC Sci Publ
– volume: 63
  start-page: 424
  year: 1991
  end-page: 9
  article-title: Descriptive epidemiology of childhood leukaemia
  publication-title: Br J Cancer
– volume: 54
  start-page: 1009
  year: 2010
  end-page: 13
  article-title: Trends in childhood cancer incidence and mortality in urban Shanghai, 1973‐2005
  publication-title: Pediatr Blood Cancer
– volume: 34
  start-page: 97
  year: 2013
  end-page: 117
  article-title: Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors
  publication-title: Annu Rev Public Health
– volume: 55
  start-page: 57
  year: 1993
  end-page: 62
  article-title: Cancer among teenagers in Denmark, 1943‐1987
  publication-title: Int J Cancer
– volume: 8
  start-page: 192
  year: 1971
  end-page: 201
  article-title: Epidemiologic patterns of Hodgkin's disease
  publication-title: Int J Cancer
– volume: 61
  start-page: 165
  year: 1995
  end-page: 9
  article-title: International patterns in the occurrence of Hodgkin's disease in children and young adult males
  publication-title: Int J Cancer
– year: 1992
– volume: 42
  start-page: 2050
  year: 2006
  end-page: 63
  article-title: Non‐Hodgkin's lymphoma incidence and survival in European children and adolescents (1978‐1997): report from the Automated Childhood Cancer Information System project
  publication-title: Eur J Cancer
– volume: 358
  start-page: 385
  year: 2001
  end-page: 7
  article-title: Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK
  publication-title: Lancet
– year: 2014
– year: 1998
– volume: 59
  start-page: B4485
  year: 2012
  article-title: On the aetiology of Hodgkin lymphoma
  publication-title: Dan Med J
– volume: 61
  start-page: 40
  year: 1995
  end-page: 3
  article-title: Cancer incidence and mortality among teenagers in Vaud, Switzerland, 1974‐1992
  publication-title: Int J Cancer
– volume: 32
  start-page: 703
  year: 1983
  end-page: 16
  article-title: Childhood cancer incidence: geographical and temporal variations
  publication-title: Int J Cancer
– volume: 64
  start-page: 83
  year: 2014
  end-page: 103
  article-title: Childhood and adolescent cancer statistics, 2014
  publication-title: CA Cancer J Clin.
– volume: 199
  start-page: 104
  year: 2004
  end-page: 17
  article-title: Causes of childhood leukaemia and lymphoma
  publication-title: Toxicol Appl Pharmacol
– volume: 120
  start-page: 2883
  year: 2014
  end-page: 92
  article-title: US lung cancer trends by histologic type
  publication-title: Cancer
– volume: 15
  start-page: 1612
  year: 2001
  end-page: 8
  article-title: Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues
  publication-title: Leukemia
– volume: 90
  start-page: 1197
  year: 2005
  end-page: 204
  article-title: Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north‐west Italy, 1967‐2001. A report of the Childhood Cancer Registry of Piedmont
  publication-title: Haematologica
– volume: 42
  start-page: 2037
  year: 2006
  end-page: 49
  article-title: Hodgkin's disease incidence and survival in European children and adolescents (1978‐1997): report from the Automated Cancer Information System project
  publication-title: Eur J Cancer
– volume: 36
  start-page: 286
  year: 2010
  end-page: 97
  article-title: Aetiology of childhood leukaemia
  publication-title: Cancer Treat Rev
– volume: 62
  start-page: 157
  year: 1976
  end-page: 62
  article-title: Prenatal exposure and carcinogenesis
  publication-title: Tumori
– volume: 16
  start-page: 210
  year: 2002
  end-page: 8
  article-title: Childhood leukaemia in Costa Rica, 1981‐96
  publication-title: Paediatr Perinat Epidemiol
– volume: 66
  start-page: 1191
  year: 1981
  end-page: 308
  article-title: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today
  publication-title: J Natl Cancer Inst
– volume: 61
  start-page: 1079
  year: 2012
  end-page: 92
  article-title: International variation in prostate cancer incidence and mortality rates
  publication-title: Eur Urol
– volume: 141
  start-page: 300
  year: 1995
  article-title: Graphical presentation of trends in rates
  publication-title: Am J Epidemiol
– volume: 24
  start-page: 1495
  year: 2015
  end-page: 506
  article-title: International Variation in Female Breast Cancer Incidence and Mortality Rates
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 42
  start-page: 2019
  year: 2006
  end-page: 36
  article-title: Leukaemia incidence and survival in children and adolescents in Europe during 1978‐1997. Report from the Automated Childhood Cancer Information System project
  publication-title: Eur J Cancer
– volume: 133
  start-page: 2201
  year: 2013
  end-page: 6
  article-title: Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in Denmark
  publication-title: Int J Cancer
– volume: 4
  start-page: 303
  year: 1990
  end-page: 24
  article-title: International variations in the incidence of childhood lymphomas
  publication-title: Paediatr Perinat Epidemiol
– year: 2013
– ident: e_1_2_6_34_1
  doi: 10.1002/pbc.22383
– ident: e_1_2_6_17_1
  doi: 10.1016/j.ejca.2006.06.001
– ident: e_1_2_6_4_1
  doi: 10.1093/jnci/66.6.1192
– ident: e_1_2_6_14_1
– ident: e_1_2_6_36_1
  doi: 10.1038/sj.leu.2402252
– ident: e_1_2_6_22_1
  doi: 10.1016/j.eururo.2012.02.054
– volume: 90
  start-page: 1197
  year: 2005
  ident: e_1_2_6_37_1
  article-title: Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north‐west Italy, 1967‐2001. A report of the Childhood Cancer Registry of Piedmont
  publication-title: Haematologica
– volume: 59
  start-page: B4485
  year: 2012
  ident: e_1_2_6_53_1
  article-title: On the aetiology of Hodgkin lymphoma
  publication-title: Dan Med J
– ident: e_1_2_6_5_1
  doi: 10.1146/annurev-publhealth-031912-114350
– ident: e_1_2_6_49_1
  doi: 10.1002/ijc.2910080203
– ident: e_1_2_6_33_1
  doi: 10.1016/S0140-6736(01)05581-7
– ident: e_1_2_6_3_1
  doi: 10.1016/j.cbi.2012.01.007
– ident: e_1_2_6_42_1
  doi: 10.1016/S0140-6736(04)17550-8
– ident: e_1_2_6_38_1
  doi: 10.1038/bjc.1996.219
– ident: e_1_2_6_16_1
  doi: 10.1111/j.1365-3016.1990.tb00654.x
– ident: e_1_2_6_12_1
  doi: 10.1002/ijc.2910320609
– ident: e_1_2_6_28_1
  doi: 10.1002/ajh.23187
– volume: 87
  start-page: 1
  year: 1988
  ident: e_1_2_6_13_1
  article-title: International incidence of childhood cancer
  publication-title: IARC Sci Publ
– ident: e_1_2_6_44_1
  doi: 10.3322/caac.21219
– volume-title: International Statistical Classification of Diseases and Related Health Problems
  year: 1992
  ident: e_1_2_6_24_1
– ident: e_1_2_6_32_1
  doi: 10.1093/jnci/djg064
– ident: e_1_2_6_26_1
  doi: 10.1093/aje/141.4.300
– ident: e_1_2_6_10_1
  doi: 10.1002/ijc.28222
– ident: e_1_2_6_6_1
– ident: e_1_2_6_35_1
  doi: 10.1002/ijc.23226
– ident: e_1_2_6_47_1
  doi: 10.3109/02841869209108173
– ident: e_1_2_6_52_1
  doi: 10.1016/j.ctrv.2010.02.004
– ident: e_1_2_6_9_1
  doi: 10.1093/jnci/85.22.1819
– ident: e_1_2_6_20_1
– ident: e_1_2_6_39_1
  doi: 10.1002/cncr.23169
– ident: e_1_2_6_30_1
  doi: 10.1016/j.ejca.2006.05.005
– ident: e_1_2_6_8_1
  doi: 10.1002/cncr.28749
– ident: e_1_2_6_29_1
  doi: 10.1016/j.ejca.2006.06.005
– volume: 62
  start-page: 157
  year: 1976
  ident: e_1_2_6_11_1
  article-title: Prenatal exposure and carcinogenesis
  publication-title: Tumori
  doi: 10.1177/030089167606200203
– ident: e_1_2_6_41_1
  doi: 10.1038/bjc.1982.90
– ident: e_1_2_6_50_1
  doi: 10.1002/ijc.2910610204
– ident: e_1_2_6_23_1
  doi: 10.1158/1055-9965.EPI-15-0535
– ident: e_1_2_6_7_1
– ident: e_1_2_6_25_1
– ident: e_1_2_6_19_1
– ident: e_1_2_6_51_1
  doi: 10.1016/j.taap.2003.12.032
– ident: e_1_2_6_2_1
  doi: 10.1093/acprof:oso/9780195149616.003.0065
– volume-title: SEER Cancer Statistics Review, 1975‐2011
  year: 2014
  ident: e_1_2_6_18_1
– ident: e_1_2_6_27_1
– ident: e_1_2_6_31_1
  doi: 10.1016/j.ejca.2006.05.012
– ident: e_1_2_6_40_1
  doi: 10.1046/j.1365-3016.2002.00422.x
– ident: e_1_2_6_46_1
  doi: 10.1002/ijc.2910610108
– ident: e_1_2_6_21_1
– ident: e_1_2_6_15_1
  doi: 10.1038/bjc.1991.98
– ident: e_1_2_6_43_1
  doi: 10.1093/jnci/91.12.1051
– volume-title: Acute myeloid leukaemia: introduction
  year: 2001
  ident: e_1_2_6_48_1
– ident: e_1_2_6_45_1
  doi: 10.1002/ijc.2910550111
SSID ssj0011504
Score 2.4610133
Snippet To enhance understanding of etiology, we examined international population‐based cancer incidence data for lymphoid leukemia, non‐Hodgkin lymphoma, Hodgkin...
To enhance understanding of etiology, we examined international population-based cancer incidence data for lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1862
SubjectTerms Adolescent
Age Distribution
Cancer
Child
Child, Preschool
childhood
Epidemiology
Female
Global Health - statistics & numerical data
Global Health - trends
Hodgkin lymphoma
Humans
Incidence
Infant
Infant, Newborn
Leukemia
Leukemia - epidemiology
lymphoid leukemia
Lymphoma
Lymphoma - epidemiology
Male
Medical research
myeloid leukemia
non‐Hodgkin lymphoma
Pediatrics
Registries
trends
Young Adult
Title International long‐term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0–19 years
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.29924
https://www.ncbi.nlm.nih.gov/pubmed/26562742
https://www.proquest.com/docview/1762935723
https://www.proquest.com/docview/1764138984
https://www.proquest.com/docview/1785231113
Volume 138
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELUQB8SFfSkUNCAOXFISx0kdcUIIBEhwQCBxQIpsx0WFkiLSHuDEJ4D4w34JY2eBsglxq-JJ5SSzvPHYbwjZ4IwlrBUlDhohdZgMPUfo0HcSTluREBixuDk7fHwSHpyzo4vgYoRsl2dhcn6IasHNWIb118bAhcy23klD29eqgb6UGi5Qs1fLAKLTijrKAJ2Cgdl1MBELS1Yhl25Vdw7Hoi8Acxiv2oCzP0kuy6nm-0xuGv2ebKjHTyyO_3yWKTJRAFHYyTVnmozodIaMHRel9lnyMrRWCJ1uejV4ejaOHHp2Hy2INAH0lxi14M6ydKYZtFNARAlmAd82K4VuCzq6f6Nv2yK_o_OA-mM2JYHtcwTlaXI7-IFfCtDRZeAOnl69CB7QHrM5cr6_d7Z74BT9GxzFqMcczJWoVqGMmNKRL2USujrQIhARoqBEcbws0OPIgEoELuhaJOea-S0llTSd0fx5Mpp2U71IIGy6XImANnEQUzopPe1LhtmNCCK8oGpks_ySsSrIzU2PjU6c0zLTGF9xbF9xjaxXonc5o8d3QvVSHeLCqLPYw8AR-UGT-jWyVg2jOZoai0h1t29lmKn9cvabDMf0H4MM_s9CrmrVTCjia1M9xweyCvPzFOPDo137Y-nvostkHAFfaKphXlAno737vl5BUNWTq9Z63gBcvh_t
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxRBEK4AJuJFRUBXEQvjgcssMz3dsz2JF0Mky2M5GEi4kEl3Ty9ZWWeJu3vAEz9B4z_kl1jd89BFMYTbZrpm0zNTj6-6ur8CeCc5z3k_zQMyQhZwnUSBskkc5JL1U6UoYkl3drh3mHSP-d6JOJmD9_VZmJIfollwc5bh_bUzcLcgvfWbNXTw2bTJmTI-Dw9cR2-fUH1qyKMc1Kk4mMOAUrGk5hUK2VZz62w0-gtiziJWH3J2nsBpPdlyp8l5ezrRbfPtBo_jfZ_mKTyusCh-KJVnCeZs8Qwe9qpq-zL8mFkuxOGoOLu--u58OU78VlpURY7kMilw4YUn6izGOCiQQCW6NXzfrxRHfRza6bn9MlDlHcNLUiG3Lwl9qyOsD5T7wT8oppB83RjD66ufUYqXZJLjFTje-Xi03Q2qFg6B4SziAaVLzJpEp9zYNNY6T0IrrBIqJSCUG0mXFTkdLZgm7ELeRUtpedw32mjXHC1ehYViVNgXgEknlEYJ1qFByuq0jmysOSU4SqR0wbRgs_6Uman4zV2bjWFWMjOzjF5x5l9xC942ohclqce_hNZqfcgqux5nEcWONBYdFrdgoxkmi3RlFlXY0dTLcFf-lfx_MlIQso4i-p_npa41M2EEsV0BnR7Ia8ztU8x297b9j5d3F30Di92j3kF2sHu4_woeEf5LXHEsEmuwMPk6ta8JY030ujelXzgiJAg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKqFeoE9YSum06qGXLInjeB31VAEroAVVVZE4VIpsx6m2LNkVu3ugJ35Cq_5DfknHzgO2L1W9reLJyknm8Y3H_gbgheQ850WaB2SELOBaRIGyIg5yyYpUKYpY0p0dPjwSe8f84CQ5WYBXzVmYih-iXXBzluH9tTPwcV5sXZOGDj6bLvlSxm_BbS5C6VR6533LHeWQTk3BHAaUiYmGVihkW-2t88HoF4Q5D1h9xOmvwMdmrtVGk9PubKq75stPNI7_-TB3YblGovi6Up17sGDL-7B0WNfaH8C3ucVCHI7KT1eXX50nx6nfSIuqzJEcJoUtHHuaznKCgxIJUqJbwffdSnFU4NDOTu3ZQFV3DC9IgdyuJPSNjrA5Tu4HbxBMIXm6CYZXl9-jFC_IICcP4bi_-2F7L6gbOASGs4gHlCwxa4ROubFprHUuQptYlaiUYFBuJF1W5HJ0wjQhF_ItWkrL48Joo11rtPgRLJaj0q4Bil4ojUpYjwYpp9M6srHmlN6oJKULpgMvmy-ZmZrd3DXZGGYVLzPL6BVn_hV34HkrOq4oPX4ntNGoQ1Zb9SSLKHKkcdJjcQeetcNkj67Ioko7mnkZ7oq_kv9NRlL-T1GG_me1UrV2JowAtiuf0wN5hfnzFLP9g23_Y_3fRZ_C0rudfvZ2_-jNY7hD4E-4yliUbMDi9HxmnxDAmupNb0g_ANiLIsA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=International+long-term+trends+and+recent+patterns+in+the+incidence+of+leukemias+and+lymphomas+among+children+and+adolescents+ages+0-19+years&rft.jtitle=International+journal+of+cancer&rft.au=Linet%2C+Martha+S&rft.au=Brown%2C+Linda+M&rft.au=Mbulaiteye%2C+Sam+M&rft.au=Check%2C+David&rft.date=2016-04-15&rft.issn=1097-0215&rft.eissn=1097-0215&rft.volume=138&rft.issue=8&rft.spage=1862&rft_id=info:doi/10.1002%2Fijc.29924&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon